Latest News in the pharma Industry

Top Stories

BARDA Awards Tetraphase Antibiotic Contract

BARDA Awards Tetraphase Antibiotic Contract

17 Feb 2012

The BARDA contract includes preclinical efficacy and toxicology studies, clinical studies, manufacturing, and associated regulatory activities for TP-434.

Read more 
Sigma-Aldrich Completes Acquisition of BioReliance

Sigma-Aldrich Completes Acquisition of BioReliance

17 Feb 2012

The acquisition will leverage SAFC’s industrial media presence and BioReliance’s biological testing services.

Read more 
Endeavour Speciality Chemicals Announces Novel Thiourea Line

Endeavour Speciality Chemicals Announces Novel Thiourea Line

17 Feb 2012

Endeavour Speciality Chemicals has announced the introduction of a line of commercially novel pyridinyl thioureas to be used as building blocks in the research of treatments for prion diseases.

Read more 
FDA Seeks $4.5B in 2013 Budget

FDA Seeks $4.5B in 2013 Budget

16 Feb 2012

In addition to recommending new user fees to support the review of generic drugs and biosimilars, the FDA budget also contains increased funding ($1.7bn) to improve the safety of drugs and other medical products, advance medical countermeasures and fac...

Read more 
Merck & Supera Farma Form Brazilian JV

Merck & Supera Farma Form Brazilian JV

16 Feb 2012

The new JV will market, distribute and sell a portfolio of innovative pharmaceutical and branded generic products from Merck, Cristália and Eurofarma solely in the Brazilian retail sector.

Read more 
Asymchem Laboratories Announces Introduction of New Manufacturing Facility

Asymchem Laboratories Announces Introduction of New Manufacturing Facility

16 Feb 2012

The facility was built to meet an annual demand for commercial projects > 5 MT and will serve to expand Asymchem's capabilities in high volume processing and back-end ingredient and intermediate production.

Read more 
Biogen Idec to Acquire Stromedix

Biogen Idec to Acquire Stromedix

15 Feb 2012

Biogen Idec will make an upfront cash payment of $75 million and additional contingent value payments of up to $487.5 million based on the achievement of certain development and approval milestones across multiple indications.

Read more 
Ockham Completes Acquisition of Nexus Oncology

Ockham Completes Acquisition of Nexus Oncology

15 Feb 2012

This merger offers an enhanced global scale, a depth of oncology-specific therapeutic expertise and new levels of operational excellence.

Read more 
BMS Completes Acquisition of Inhibitex

BMS Completes Acquisition of Inhibitex

14 Feb 2012

Bristol-Myers Squibb has announced the successful completion of the tender offer by Bristol-Myers Squibb Company for all of the outstanding shares of common stock of Inhibitex, Inc.

Read more 
Particle Sciences Collaborates with Chemo

Particle Sciences Collaborates with Chemo

14 Feb 2012

Under the agreement, the two companies will leverage each other’s strengths to provide a start to finish contract solution for those looking to develop and market hormone eluting devices.

Read more 
Bosch Packaging Technology to Acquire Eisai's Machinery Business

Bosch Packaging Technology to Acquire Eisai's Machinery Business

14 Feb 2012

Bosch Packaging Technology is to acquire Eisai’s machinery business to strengthen its position in the pharmaceutical market.

Read more 
Elan Reports Fourth Quarter and Full-Year 2011 Results

Elan Reports Fourth Quarter and Full-Year 2011 Results

10 Feb 2012

Total revenue for the full-year 2011 increased by 19% to $1,068.1 million, from $895.6 million for the full-year 2010.

Read more